Church & Dwight Co., Inc. (CHD)
After hours:
| Previous close | 103.26 |
| Open | 103.02 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's range | 102.23 - 103.81 |
| 52-week range | 82.25 - 110.31 |
| Volume | |
| Avg. volume | 1,559,880 |
| Market cap | 25.351B |
| Beta (5Y monthly) | 0.54 |
| PE ratio (TTM) | 31.96 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.14 (1.10%) |
| Ex-dividend date | 15 Aug 2024 |
| 1y target est | N/A |
- Zacks
Church & Dwight Stock's Potential: Can CHD Overcome Recent Hurdles?
Church & Dwight's strong brand portfolio, pricing strategies and robust online sales aid amid high costs and volatile consumer behavior.
- Zacks
Is the Options Market Predicting a Spike in Church & Dwight (CHD) Stock?
Investors need to pay close attention to Church & Dwight (CHD) stock based on the movements in the options market lately.
- Reuters
Trojan condoms contain 'forever chemicals,' lawsuit claims
A new lawsuit on Monday claims that Trojan condoms are not safe because they contain toxic "forever chemicals," which have been linked to cancer. In a proposed class action filed in Manhattan federal court, the plaintiff Matthew Goodman said Church & Dwight's products, advertised as "America's #1 Condom," are unfit for their intended purpose because they contain per- and polyfluoroalkyl substances, or PFAS. Goodman said independent lab testing of the Trojan Ultra Thin condoms that he bought at a Manhattan pharmacy found a presence of organic fluorine, which is "practically nonexistent" outside its use in man-made PFAS chemicals.
